The Marquie Group Announces Cancellation of Buy-Sell Agreement
ST. PETERSBURG, Fla., Aug. 26, 2025 (GLOBE NEWSWIRE) -- The Marquie Group Inc. (“TMGI” or the “Company”) (OTCID:TMGI), today publicly announced via a Form 8-K filing with the U. S.…
Producers Online
Finding producers online involves identifying the right platforms, networks, and resources where producers showcase their work or are actively seeking projects. Here are some effective strategies:
When reaching out to producers, be clear about your project needs, budget, and timelines. This helps in finding the right match quickly
ST. PETERSBURG, Fla., Aug. 26, 2025 (GLOBE NEWSWIRE) -- The Marquie Group Inc. (“TMGI” or the “Company”) (OTCID:TMGI), today publicly announced via a Form 8-K filing with the U. S.…
PARSIPPANY, N.J., Aug. 26, 2025 (GLOBE NEWSWIRE) -- Embecta Corp. ("embecta") (Nasdaq: EMBC), a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical…
Sioux Falls, S.D., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Today POET, the world’s largest producer of biofuel, announced it has signed an agreement to acquire Green Plains Obion, a bioethanol…
Avante Corp. achieved 11% year-over-year revenue growth and 25% improvement in Recurring Monthly Revenue in the fiscal first quarter ended June 30, 2025. The Company achieved Adjusted EBITDA from continuing…
Imdelltra is a first-in-class immunotherapy for the treatment of extensive-stage small cell lung cancer (ES-SCLC) marketed by AmgenRoyalty Pharma to pay $885 million upfront; BeOne Medicines to retain a $65…
VANCOUVER, British Columbia, Aug. 25, 2025 (GLOBE NEWSWIRE) -- Pan American Silver Corp. (NYSE: PAAS) (TSX: PAAS) ("Pan American") and MAG Silver Corp. (NYSE American: MAG) (TSX:MAG) ("MAG") are pleased…
MILWAUKEE, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Brady Corporation (NYSE: BRC), will announce its fiscal 2025 fourth quarter financial results on Thursday, September 4, 2025. A conference call will be…
LA JOLLA, Calif., Aug. 26, 2025 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ: MNOV) and the Standard Market of the Tokyo Stock…
Acquisition expected to diversify and accelerate double-digit revenue growth with FUROSCIX®, an innovative treatment for edema due to chronic heart failure and chronic kidney disease, addressing significant unmet needUpfront cash…
On 5 May 2025, Schouw & Co. initiated a share buy-back programme as outlined in Company Announcement no. 20 of 2 May 2025. Under the programme, Schouw & Co. will…